Human pegivirus-1 (HPgV-1, GBV-C) RNA prevalence and genotype diversity among volunteer blood donors from an intra-hospital hemotherapy service in Southern Brazil.


Journal

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
ISSN: 1473-0502
Titre abrégé: Transfus Apher Sci
Pays: England
ID NLM: 101095653

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 22 10 2018
accepted: 22 01 2019
pubmed: 3 2 2019
medline: 30 8 2019
entrez: 3 2 2019
Statut: ppublish

Résumé

Human pegivirus (HPgV-1, GBV-C) is classified within the Pegivirus genus of the Flaviviriade family. The natural history of HPgV-1 infection is still unclear, however, the main route of viral transmission seems to be the parenteral one. The detection of HPgV-1 viremia in blood donors without parenteral exposure demonstrates that other routes of HPgV-1 transmission might also exist. The objective of the present study was to evaluate the prevalence of HPgV-1 RNA and circulating genotypes among blood donors from a intra-hospital Hemotherapy Service localized in the Santa Maria city, central part of the Rio Grande do Sul State in the extreme South of Brazil. Blood samples were obtained from 373 volunteer blood donors and tested for the presence of HPgV-1 RNA. All positive for RNA samples were submitted to sequencing and phylogenetic analysis. The prevalence of the HPgV-1 RNA was 5.9% (22/373). The performed phylogenetic analysis demonstrated a predominant detection of genotype 2 with its both subgenotype forms (95.5% of all isolates i.e 54.5% belonging to subgenotype 2 A and 40.9% belonging to subgenotype 2B). Only one sequence was classified as genotype 3 (1/22, 4.5%). Our study demonstrates the circulation pattern and genotypes of HPgV-1 among volunteer blood donors of South Brazil, and adds to the global knowledge of the natural history and possible transmission routes of this viral agent with putative impact on the area of hemotherapy.

Identifiants

pubmed: 30709590
pii: S1473-0502(18)30411-7
doi: 10.1016/j.transci.2019.01.002
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Pagination

174-178

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Svetoslav Nanev Slavov (SN)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 14051-140, Ribeirão Preto, São Paulo, Brazil; Department of Internal Medicine, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 14048-900, Ribeirão Preto, São Paulo, Brazil. Electronic address: svetoslav.slavov@hemocentro.fmrp.usp.br.

Roberta Maraninchi Silveira (RM)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 14051-140, Ribeirão Preto, São Paulo, Brazil.

Evandra Strazza Rodrigues (ES)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 14051-140, Ribeirão Preto, São Paulo, Brazil.

Cristiane Fração Diefenbach (CF)

Hematologic and Oncologic Service, University Hospital of Santa Maria, Federal University of Santa Maria, 97105-340, Santa Maria, Rio Grande do Sul, Brazil.

Ana Maria Zimmermann (AM)

Hemotherapy Service, Hospital "Dr Astrogildo de Azevedo", 97015-372, Santa Maria, Rio Grande do Sul, Brazil.

Dimas Tadeu Covas (DT)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 14051-140, Ribeirão Preto, São Paulo, Brazil.

Simone Kashima (S)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 14051-140, Ribeirão Preto, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH